Atlas Trials

A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)

Clinical trial NCT04185415 · COMPLETED

Trial details

NCT number
NCT04185415
Sponsor
UCB Biopharma SRL
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Progressive Supranuclear Palsy
Start date
2019-12-03
Primary completion
2021-11-17
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.